Close
Almac
Achema middle east

Mannatech adds vitamin D to omega-3 supplement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Novartis to Lower Innovative Medicines Price in the US

Novartis, which is a leading global innovative medicines company,...

New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices

President Donald Trump on December 19, 2025, said that...
- Advertisement -

Mannatech, a developer and provider of nutritional supplements and skin care products based on Real Food Technology solutions, has added vitamin D to its omega-3 supplement. The new Omega-3 with Vitamin D3 capsules now comprise 830 IUs of vitamin D3 and continue to provide more than 1,000mg of concentrated EPA and DHA fatty acids.Mannatech’s decision to add vitamin D to its popular omega-3 supplement was prompted by expanding scientific research documenting the extensive health benefits of vitamin D.

Mannatech co-CEO and chief science officer Robert Sinnott said by adding vitamin D to their omega-3 supplement at no additional charge, they are making it easier for consumers to meet the recommended intake of the essential nutrients their bodies need but often don’t receive through a modern Western diet.

Latest stories

Related stories

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Novartis to Lower Innovative Medicines Price in the US

Novartis, which is a leading global innovative medicines company,...

New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices

President Donald Trump on December 19, 2025, said that...

First GLP-1 Pill for Obesity by Novo Nordisk Approved by FDA

The U.S. Food and Drug Administration – FDA on...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »